Molbio Diagnostics Limited

Global point-of-care (POC) molecular diagnostics company engaged in research, development, manufacturing and commercialization of rapid diagnostic solutions for infectious and non-communicable diseases. Developer of the proprietary 'Truenat' platform, a portable, battery-operated PCR-based molecular diagnostics system for resource-limited settings. Offers molecular testing solutions for over 30 diseases through 43 diagnostic assays including TB, COVID-19, HIV, Hepatitis B & C and HPV, and also provides radiology, digital pathology and breast health screening solutions through subsidiaries and strategic collaborations. Operates six manufacturing facilities across India and serves customers in over 90 countries.